Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976 Oct 4;213(4):369-76.
doi: 10.1007/BF00316278.

Measles virus infection and multiple sclerosis: serological studies

Measles virus infection and multiple sclerosis: serological studies

W Cendrowski et al. J Neurol. .

Abstract

In 159 patients out of 161 with multiple sclerosis (MS), a significant rise in the level of measles hemagglutination inhibition (HI) antibody was found in the serum and in 92 MS patients the occurrence of measles HI antibody in the CSF was significantly more frequent. MS patients showed CSF humoral response against measles virus by neutralizing test (NV) (76%) more often than by hemagglutination test (37%). CSF FA antibody was found in 60%. In the serum of MS patients the presence of NV, HAd, FA, and GP-RNP was observed. 87% of MS patients showed lowered serum: CSF NV or HI antibody ratios and 78% had a diminished FA antibody ratio. Longitudinal study of serum HI measles virus antibody showed no substantial changes over longer period of the disease. Higher CSF measles antibody titer was found in more disabled patients with a malignant course of the disease (P less than 0.001). It is concluded that either persistent infection with proviruses or nonspecific stimulation of certain clones in individuals with genetic susceptibility provides for an excessive synthesis of humoral viral antibodies in MS.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ann N Y Acad Sci. 1965 Mar 31;122:457-66 - PubMed
    1. Transplant Rev. 1975;22:148-63 - PubMed
    1. Ann Rheum Dis. 1972 May;31(3):192-5 - PubMed
    1. J Neurol Sci. 1975 Feb;24(2):201-19 - PubMed
    1. Acta Neurol Scand. 1975 May;51(5):333-46 - PubMed

Substances